$COGT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cogent Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cogent Biosciences, Inc.. Get notifications about new insider transactions in Cogent Biosciences, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | COGT | Cogent Biosciences ... | Kearns Evan | Chief Legal Officer | Option Exercise | A | 8.93 | 260,000 | 2,321,800 | 260,000 | |
| Apr 28 2021 | COGT | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Sell | S | 8.86 | 17,813 | 157,823 | 3,841 | 21.7 K to 3.8 K (-82.26 %) |
| Apr 05 2021 | COGT | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 9.08 | 2,121 | 19,259 | 2,121 | |
| Apr 05 2021 | COGT | Cogent Biosciences ... | Ros Matthew | Director | Option Exercise | A | 9.08 | 2,068 | 18,777 | 2,068 | |
| Mar 15 2021 | UMRX | Cogent Biosciences ... | Harwin Peter Evan | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
| Mar 15 2021 | UMRX | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
| Mar 15 2021 | UMRX | Cogent Biosciences ... | Shegog Todd | Director | Option Exercise | A | 8.45 | 22,500 | 190,125 | 22,500 | |
| Mar 15 2021 | UMRX | Cogent Biosciences ... | Ros Matthew | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
| Mar 15 2021 | UMRX | Cogent Biosciences ... | CAIN CHRISTOPHER W. | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
| Mar 15 2021 | UMRX | Cogent Biosciences ... | Morris Arlene | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
| Mar 01 2021 | UMRX | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Grant | A | 0.00 | 524 | 0 | 21,654 | 21.1 K to 21.7 K (+2.48 %) |
| Feb 24 2021 | UMRX | Cogent Biosciences ... | Shegog Todd | Director | Option Exercise | A | 8.59 | 37,500 | 322,125 | 37,500 | |
| Feb 12 2021 | UMRX | Cogent Biosciences ... | Robbins Andrew R | President and CEO | Option Exercise | A | 10.17 | 315,200 | 3,205,584 | 315,200 | |
| Feb 12 2021 | UMRX | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Option Exercise | A | 10.17 | 270,746 | 2,753,487 | 270,746 | |
| Feb 12 2021 | UMRX | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Option Exercise | A | 10.17 | 111,300 | 1,131,921 | 111,300 | |
| Feb 12 2021 | UMRX | Cogent Biosciences ... | Sachs Jessica | Chief Medical Offic ... | Option Exercise | A | 10.17 | 126,500 | 1,286,505 | 126,500 | |
| Feb 02 2021 | UMRX | Cogent Biosciences ... | Sachs Jessica | Chief Medical Offic ... | Option Exercise | A | 9.10 | 400,000 | 3,640,000 | 400,000 | |
| Jan 06 2021 | UMRX | Cogent Biosciences ... | Ros Matthew | Director | Option Exercise | A | 7.62 | 1,641 | 12,503 | 1,641 | |
| Jan 06 2021 | UMRX | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 7.62 | 1,575 | 12,000 | 1,575 | |
| Dec 07 2020 | UMRX | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Grant | A | 0.00 | 1,748 | 0 | 1,748 | 0 to 1.7 K |
| Oct 27 2020 | UMRX | Cogent Biosciences ... | Robbins Andrew R | President and CEO | Option Exercise | A | 2.79 | 7,442,421 | 20,764,355 | 7,442,421 | |
| Oct 15 2020 | UMRX | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Option Exercise | A | 2.89 | 695,700 | 2,010,573 | 695,700 | |
| Oct 02 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.26 | 8,878 | 20,064 | 8,878 | |
| Oct 02 2020 | UMRX | Unum Therapeutics ... | Ros Matthew | Director | Option Exercise | A | 2.26 | 9,247 | 20,898 | 9,247 | |
| Aug 31 2020 | UMRX | Unum Therapeutics ... | Harwin Peter Evan | Director | Option Exercise | A | 2.77 | 28,661 | 79,391 | 28,661 | |
| Aug 31 2020 | UMRX | Unum Therapeutics ... | CAIN CHRISTOPHER W. | Director | Option Exercise | A | 2.77 | 28,661 | 79,391 | 28,661 | |
| Aug 18 2020 | UMRX | Unum Therapeutics ... | Venrock Healthcare Capital Par ... | 10% Owner | Buy | P | 2.62 | 101,000 | 264,620 | 4,355,273 | 4.3 M to 4.4 M (+2.37 %) |
| Aug 18 2020 | UMRX | Unum Therapeutics ... | Venrock Healthcare Capital Par ... | 10% Owner | Buy | P | 2.57 | 250,000 | 642,500 | 4,254,273 | 4 M to 4.3 M (+6.24 %) |
| Aug 18 2020 | UMRX | Unum Therapeutics ... | Venrock Healthcare Capital Par ... | 10% Owner | Buy | P | 2.30 | 100,000 | 230,000 | 4,004,273 | 3.9 M to 4 M (+2.56 %) |
| Jul 13 2020 | UMRX | Unum Therapeutics ... | Fairmount Funds Management LLC | 10% Owner | Option Exercise | P | 0.00 | 19,035 | 0 | 55,500 | |
| Jul 13 2020 | UMRX | Unum Therapeutics ... | Fairmount Funds Management LLC | 10% Owner | Option Exercise | P | 0.00 | 3,692 | 0 | 11,914 | |
| Jul 13 2020 | UMRX | Unum Therapeutics ... | Fairmount Funds Management LLC | 10% Owner | Option Exercise | P | 0.00 | 19,035 | 0 | 55,500 | |
| Jul 13 2020 | UMRX | Unum Therapeutics ... | Fairmount Funds Management LLC | 10% Owner | Option Exercise | P | 0.00 | 3,692 | 0 | 11,914 | |
| Jul 08 2020 | UMRX | Unum Therapeutics ... | Green John L. | Chief Financial Off ... | Option Exercise | M | 0.00 | 109,459 | 0 | 0 | |
| Jul 08 2020 | UMRX | Unum Therapeutics ... | Green John L. | Chief Financial Off ... | Payment of Exercise | F | 2.20 | 31,873 | 70,121 | 77,586 | 109.5 K to 77.6 K (-29.12 %) |
| Jul 08 2020 | UMRX | Unum Therapeutics ... | Green John L. | Chief Financial Off ... | Buy | M | 0.00 | 109,459 | 0 | 109,459 | 0 to 109.5 K |
| Jul 08 2020 | UMRX | Unum Therapeutics ... | Fairmount Funds Management LLC | 10% Owner | Option Exercise | J | 0.00 | 36,465 | 0 | 36,465 | |
| Jul 08 2020 | UMRX | Unum Therapeutics ... | Fairmount Funds Management LLC | 10% Owner | Option Exercise | J | 0.00 | 8,222 | 0 | 8,222 | |
| Jul 08 2020 | UMRX | Unum Therapeutics ... | Fairmount Funds Management LLC | 10% Owner | Buy | J | 0.00 | 5,088,497 | 0 | 5,088,497 | 0 to 5.1 M |
| Jul 08 2020 | UMRX | Unum Therapeutics ... | Fairmount Funds Management LLC | 10% Owner | Buy | J | 0.00 | 1,147,406 | 0 | 1,147,406 | 0 to 1.1 M |
| Jul 06 2020 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 0.47 | 61,338 | 28,829 | 61,338 | |
| Jul 06 2020 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 0.47 | 61,338 | 28,829 | 61,338 | |
| Jul 06 2020 | UMRX | Unum Therapeutics ... | Ros Matthew | Director | Option Exercise | A | 0.47 | 35,280 | 16,582 | 35,280 | |
| Jul 06 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.47 | 38,487 | 18,089 | 38,487 | |
| Jul 06 2020 | UMRX | Unum Therapeutics ... | Aldag Jorn | Director | Option Exercise | A | 0.47 | 40,090 | 18,842 | 40,090 | |
| Jun 11 2020 | UMRX | Unum Therapeutics ... | Ros Matthew | Director | Option Exercise | A | 0.63 | 14,331 | 9,029 | 14,331 | |
| Jun 11 2020 | UMRX | Unum Therapeutics ... | Morris Arlene | Director | Option Exercise | A | 0.63 | 14,331 | 9,029 | 14,331 | |
| Jun 11 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.63 | 14,331 | 9,029 | 14,331 | |
| Jun 11 2020 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 0.63 | 14,331 | 9,029 | 14,331 | |
| Jun 11 2020 | UMRX | Unum Therapeutics ... | Aldag Jorn | Director | Option Exercise | A | 0.63 | 14,331 | 9,029 | 14,331 | |
| Apr 08 2020 | UMRX | Unum Therapeutics ... | Ros Matthew | Director | Option Exercise | A | 0.35 | 49,887 | 17,436 | 49,887 | |
| Apr 08 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.35 | 54,422 | 19,020 | 54,422 | |
| Apr 08 2020 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 0.35 | 86,735 | 30,314 | 86,735 | |
| Apr 08 2020 | UMRX | Unum Therapeutics ... | Aldag Jorn | Director | Option Exercise | A | 0.35 | 56,690 | 19,813 | 56,690 | |
| Feb 13 2020 | UMRX | Unum Therapeutics ... | Sachs Jessica | Chief Medical Offic ... | Option Exercise | A | 0.80 | 133,200 | 106,560 | 133,200 | |
| Feb 13 2020 | UMRX | Unum Therapeutics ... | Green John L. | See Remarks | Option Exercise | A | 0.80 | 64,400 | 51,520 | 64,400 | |
| Feb 13 2020 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | A | 0.80 | 153,600 | 122,880 | 153,600 | |
| Nov 21 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | A | 0.69 | 280,000 | 193,200 | 280,000 | |
| Nov 21 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | A | 0.69 | 280,000 | 193,200 | 280,000 | |
| Nov 21 2019 | UMRX | Unum Therapeutics ... | Green John L. | See Remarks | Option Exercise | A | 0.00 | 109,459 | 0 | 109,459 | |
| Nov 21 2019 | UMRX | Unum Therapeutics ... | Green John L. | See Remarks | Option Exercise | A | 0.00 | 109,459 | 0 | 109,459 | |
| Oct 03 2019 | UMRX | Unum Therapeutics ... | Ros Matthew | Director | Option Exercise | A | 1.41 | 12,509 | 17,638 | 12,509 | |
| Oct 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 1.41 | 13,646 | 19,241 | 13,646 | |
| Oct 03 2019 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 1.41 | 20,611 | 29,062 | 20,611 | |
| Oct 03 2019 | UMRX | Unum Therapeutics ... | Aldag Jorn | Director | Option Exercise | A | 1.41 | 15,352 | 21,646 | 15,352 | |
| Jul 29 2019 | UMRX | Unum Therapeutics ... | Ros Matthew | Director | Option Exercise | A | 2.05 | 28,661 | 58,755 | 28,661 | |
| Jul 29 2019 | UMRX | Unum Therapeutics ... | Morris Arlene | Director | Option Exercise | A | 2.05 | 28,661 | 58,755 | 28,661 | |
| Jul 22 2019 | UMRX | Unum Therapeutics ... | Sachs Jessica | Chief Medical Offic ... | Option Exercise | A | 2.61 | 123,800 | 323,118 | 123,800 | |
| Jul 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.41 | 6,199 | 14,940 | 6,199 | |
| Jul 03 2019 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 2.41 | 10,285 | 24,787 | 10,285 | |
| Jun 25 2019 | UMRX | Unum Therapeutics ... | Osborne Matthew Scott | Chief Financial Off ... | Option Exercise | A | 2.44 | 190,000 | 463,600 | 190,000 | |
| Jun 25 2019 | UMRX | Unum Therapeutics ... | Osborne Matthew Scott | Chief Financial Off ... | Option Exercise | A | 2.44 | 190,000 | 463,600 | 190,000 | |
| Jun 20 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.70 | 14,331 | 38,694 | 14,331 | |
| Jun 20 2019 | UMRX | Unum Therapeutics ... | Aldag Jorn | Director | Option Exercise | A | 2.70 | 14,331 | 38,694 | 14,331 | |
| Jun 18 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 2.43 | 7,881 | 19,151 | 7,881 | |
| Jun 18 2019 | UMRX | Unum Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | A | 2.43 | 7,131 | 17,328 | 7,131 | |
| Apr 26 2019 | UMRX | Unum Therapeutics ... | Green John L. | See Remarks | Option Exercise | A | 3.52 | 16,814 | 59,185 | 16,814 | |
| Apr 11 2019 | UMRX | Unum Therapeutics ... | WILSON CHARLES | Chief Executive Off ... | Option Exercise | A | 4.36 | 174,400 | 760,384 | 174,400 | |
| Apr 11 2019 | UMRX | Unum Therapeutics ... | VASCONCELLES MICHAEL | Chief Medical Offic ... | Option Exercise | A | 4.36 | 61,900 | 269,884 | 61,900 | |
| Apr 11 2019 | UMRX | Unum Therapeutics ... | HODGE GEOFFREY | Chief Technical Off ... | Option Exercise | A | 4.36 | 28,000 | 122,080 | 28,000 | |
| Apr 11 2019 | UMRX | Unum Therapeutics ... | Green John L. | See Remarks | Option Exercise | A | 4.36 | 21,017 | 91,634 | 21,017 | |
| Apr 11 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | A | 4.36 | 69,700 | 303,892 | 69,700 | |
| Apr 03 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 4.40 | 4,829 | 21,248 | 4,829 | |
| Apr 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.40 | 4,047 | 17,807 | 4,047 | |
| Apr 03 2019 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 4.40 | 6,714 | 29,542 | 6,714 | |
| Mar 26 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | A | 0.18 | 11,485 | 2,067 | 329,145 | |
| Mar 26 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Sell | S | 4.12 | 11,485 | 47,334 | 0 | 11.5 K to 0 (-100.00 %) |
| Mar 26 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Buy | M | 0.18 | 11,485 | 2,067 | 11,485 | 0 to 11.5 K |
| Feb 26 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | M | 0.18 | 11,485 | 2,067 | 340,630 | |
| Feb 26 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Sell | S | 4.25 | 11,485 | 48,853 | 0 | 11.5 K to 0 (-100.00 %) |
| Feb 26 2019 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Buy | M | 0.18 | 11,485 | 2,067 | 11,485 | 0 to 11.5 K |
| Jan 04 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 4.47 | 4,860 | 21,724 | 4,860 | |
| Jan 04 2019 | UMRX | Unum Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | A | 4.47 | 4,397 | 19,655 | 4,397 | |
| Jan 04 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.47 | 4,073 | 18,206 | 4,073 | |
| Jan 04 2019 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 4.47 | 6,757 | 30,204 | 6,757 | |
| Jan 04 2019 | UMRX | Unum Therapeutics ... | Aldag Jorn | Director | Option Exercise | A | 4.47 | 4,999 | 22,346 | 4,999 | |
| Dec 28 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | M | 0.18 | 11,485 | 2,067 | 352,115 | |
| Dec 28 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Sell | S | 4.05 | 11,485 | 46,487 | 0 | 11.5 K to 0 (-100.00 %) |
| Dec 28 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Buy | M | 0.18 | 11,485 | 2,067 | 11,485 | 0 to 11.5 K |
| Nov 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | M | 0.18 | 11,485 | 2,067 | 363,600 | |
| Nov 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | M | 0.18 | 11,485 | 2,067 | 363,600 | |
| Nov 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Sell | S | 7.00 | 11,485 | 80,444 | 0 | 11.5 K to 0 (-100.00 %) |
| Nov 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Sell | S | 7.00 | 11,485 | 80,444 | 0 | 11.5 K to 0 (-100.00 %) |
| Nov 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Buy | M | 0.18 | 11,485 | 2,067 | 11,485 | 0 to 11.5 K |
| Nov 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Buy | M | 0.18 | 11,485 | 2,067 | 11,485 | 0 to 11.5 K |
| Oct 29 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | M | 0.18 | 11,485 | 2,067 | 375,085 | |
| Oct 29 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Sell | S | 8.46 | 11,485 | 97,201 | 0 | 11.5 K to 0 (-100.00 %) |
| Oct 29 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Buy | M | 0.18 | 11,485 | 2,067 | 11,485 | 0 to 11.5 K |
| Oct 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 10.37 | 2,111 | 21,891 | 2,111 | |
| Oct 03 2018 | UMRX | Unum Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | A | 10.37 | 1,910 | 19,807 | 1,910 | |
| Oct 03 2018 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 10.37 | 1,769 | 18,345 | 1,769 | |
| Oct 03 2018 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 10.37 | 2,935 | 30,436 | 2,935 | |
| Oct 03 2018 | UMRX | Unum Therapeutics ... | Aldag Jorn | Director | Option Exercise | A | 10.37 | 2,171 | 22,513 | 2,171 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 14.57 | 1,504 | 21,913 | 1,504 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | A | 14.57 | 1,361 | 19,830 | 1,361 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 14.57 | 1,261 | 18,373 | 1,261 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Option Exercise | M | 0.18 | 11,485 | 2,067 | 386,570 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Sell | S | 12.47 | 11,485 | 143,181 | 0 | 11.5 K to 0 (-100.00 %) |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Ettenberg Seth | Chief Scientific Of ... | Buy | M | 0.18 | 11,485 | 2,067 | 11,485 | 0 to 11.5 K |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | A | 14.57 | 2,092 | 30,480 | 2,092 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Aldag Jorn | Director | Option Exercise | A | 14.57 | 1,547 | 22,540 | 1,547 | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FIL Ltd | Option Exercise | C | 0.00 | 42,931 | 0 | 0 | ||
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FIL Ltd | Option Exercise | C | 0.00 | 1,744,310 | 0 | 0 | ||
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FIL Ltd | Buy | C | 0.00 | 27,342 | 0 | 1,138,274 | 1.1 M to 1.1 M (+2.46 %) | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FIL Ltd | Buy | C | 0.00 | 1,110,932 | 0 | 1,110,932 | 0 to 1.1 M | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Option Exercise | C | 0.00 | 877 | 0 | 0 | ||
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Option Exercise | C | 0.00 | 73,065 | 0 | 0 | ||
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Option Exercise | C | 0.00 | 13,505 | 0 | 0 | ||
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Option Exercise | C | 0.00 | 35,614 | 0 | 0 | ||
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Option Exercise | C | 0.00 | 2,968,650 | 0 | 0 | ||
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Option Exercise | C | 0.00 | 548,702 | 0 | 0 | ||
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Buy | C | 0.00 | 558 | 0 | 23,240 | 22.7 K to 23.2 K (+2.46 %) | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Buy | C | 0.00 | 22,682 | 0 | 22,682 | 0 to 22.7 K | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Buy | C | 0.00 | 46,534 | 0 | 1,937,235 | 1.9 M to 1.9 M (+2.46 %) | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Buy | C | 0.00 | 1,890,701 | 0 | 1,890,701 | 0 to 1.9 M | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Buy | P | 12.00 | 94,052 | 1,128,624 | 452,115 | 358.1 K to 452.1 K (+26.27 %) | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Buy | C | 0.00 | 8,601 | 0 | 358,063 | 349.5 K to 358.1 K (+2.46 %) | |
| Apr 05 2018 | UMRX | Unum Therapeutics ... | FMR LLC | Buy | C | 0.00 | 349,462 | 0 | 349,462 | 0 to 349.5 K | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Atlas Venture Fund IX, L.P. | 10% Owner | Option Exercise | C | 0.00 | 83,037 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Atlas Venture Fund IX, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,184,446 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Atlas Venture Fund IX, L.P. | 10% Owner | Buy | P | 12.00 | 94,052 | 1,128,624 | 3,361,535 | 3.3 M to 3.4 M (+2.88 %) |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Atlas Venture Fund IX, L.P. | 10% Owner | Buy | C | 0.00 | 83,037 | 0 | 3,267,483 | 3.2 M to 3.3 M (+2.61 %) |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Atlas Venture Fund IX, L.P. | 10% Owner | Buy | C | 0.00 | 3,184,446 | 0 | 3,184,446 | 0 to 3.2 M |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | C | 0.00 | 83,037 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Option Exercise | C | 0.00 | 3,184,446 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Buy | P | 12.00 | 94,052 | 1,128,624 | 3,361,535 | 3.3 M to 3.4 M (+2.88 %) |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Buy | C | 0.00 | 83,037 | 0 | 3,267,483 | 3.2 M to 3.3 M (+2.61 %) |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Booth Bruce | Director | Buy | C | 0.00 | 3,184,446 | 0 | 3,184,446 | 0 to 3.2 M |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 977,836 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 977,835 | 0 | 0 |